Szczeklik A, Podolec Z
Int Arch Allergy Appl Immunol. 1976;50(3):328-40.
The effect of isoprenaline and three different beta-adrenergic blocking agents on blood eosinophilia was evaluated in the rat. Eosinopenic effect of isoprenaline was antagonized by intraperitoneal pretreatment with propranolol and by high but not low doses of practolol. Sotalol, a beta-blocker which in contrast to propranolol does not penetrate the blood-brain barrier, did not affect the eosinophil count when injected intraperitoneally, but produced a marked increase in number of circulating eosinophils following intracerebroventricular injection. Intraperitoneal administration of isoprenaline and propranolol as well as intracerebroventricular injection of sotalol did not affect eosinophil count in adrenalectomized or hypophysectomized rats. These results suggest that beta-adrenergic agents regulate the number of circulating eosinophils through a central mechanism and that presence of both hypophysis and adrenal glands is required for this action.
在大鼠中评估了异丙肾上腺素和三种不同的β-肾上腺素能阻滞剂对血液嗜酸性粒细胞的影响。腹腔内预先给予普萘洛尔以及高剂量而非低剂量的普拉洛尔可拮抗异丙肾上腺素的嗜酸性粒细胞减少作用。索他洛尔是一种β受体阻滞剂,与普萘洛尔不同,它不能穿透血脑屏障,腹腔注射时不影响嗜酸性粒细胞计数,但脑室内注射后会使循环嗜酸性粒细胞数量显著增加。腹腔注射异丙肾上腺素和普萘洛尔以及脑室内注射索他洛尔对肾上腺切除或垂体切除的大鼠的嗜酸性粒细胞计数没有影响。这些结果表明,β-肾上腺素能药物通过中枢机制调节循环嗜酸性粒细胞的数量,并且这种作用需要垂体和肾上腺的存在。